Auto-immune manifestations in non-Hodgkin's lymphoma;Manifestations dysimmunitaires associées aux lymphomes

Revue de Medecine Interne

Volumn 26, Issue 7, 2005, Pages 557-571

  Jardin, F ^a   Levesque H ^b   Tilly, H ^a  

^a CENTRE HENRI BECQUEREL   (France)

^b Dept de Médecine Interne Ctr Hosp Univ Rouen Boisguillaume   (France)

Author keywords

Auto immunity; Auto immunit ; Lymphome non hodgkinien; Non Hodgkin's lymphoma; Rituximab

Indexed keywords

ANTIBODY; AUTOANTIBODY; ENDOMYSIUM ANTIBODY; FAS LIGAND; FLUDARABINE; INTERFERON; PHOSPHOLIPID ANTIBODY; RITUXIMAB;

ARTHRITIS; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BLEEDING DISORDER; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; CLINICAL FEATURE; CRYOGLOBULINEMIA; CYTOPENIA; GLOMERULOPATHY; HEMATOLOGY; HISTOLOGY; HUMAN; IMMUNITY; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE PROLIFERATION; LYMPHOPROLIFERATIVE DISEASE; MYOSITIS; NEUROPATHY; NONHODGKIN LYMPHOMA; PATHOPHYSIOLOGY; PEMPHIGUS; PERIPHERAL NERVOUS SYSTEM; POLYNEUROPATHY; PREVALENCE; PROGNOSIS; REVIEW; SKIN DISEASE; SYSTEMIC VASCULITIS; T LYMPHOCYTE; TUMOR CELL; URTICARIA; VASCULITIS;

EID: 21744459252     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.revmed.2004.11.011     Document Type: Short Survey

References (169)

1. X. Mariette, D. Cazals-Hatem, J. Warszawki, F. Liote, N. Balandraud, and J. Sibilia Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France Blood 99 2002 3909 3915
2. M. Ehrenfeld, M. Abu-Shakra, D. Buskila, and Y. Shoenfeld The dual association between lymphoma and auto-immunity Blood Cells Mol. Dis. 27 2001 750 756
3. C.M. Allen, and C. Camisa Paraneoplastic pemphigus: a review of the literature Oral Dis. 6 2000 208 214
4. A.R. Ahmed, M.M. Avram, and L.M. Duncan Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 23-2003. A 79-year-old woman with gastric lymphoma and erosive mucosal and cutaneous lesions N. Engl. J. Med. 349 2003 382 391
5. V. Descamps, and S. Belaich Pemphigus parańoplasique Presse Med. 28 1999 363 367
6. T.E. Hutson, and G.S. Hoffman Temporal concurrence of vasculitis and cancer: a report of 12 cases Arthritis Care Res. 13 2000 417 423
7. A.M. Farrell, S.C. Stern, K. El-Ghariani, A. Frankel, D. Woodrow, and B. Muller Splenic lymphoma with villous lymphocytes presenting as leucocytoclastic vasculitis Clin. Exp. Dermatol. 24 1999 19 22
8. C.M. Magro, and A.N. Crowson A clinical and histologic study of 37 cases of immunoglobulin A-associated vasculitis Am. J. Dermatopathol. 21 1999 234 240
9. N.A. Pavlidis, G. Klouvas, M. Tsokos, M. Bai, and H.M. Moutsopoulos Cutaneous lymphocytic vasculopathy in lymphoproliferative disorders - a paraneoplastic lymphocytic vasculitis of the skin Leuk. Lymphoma 16 1995 477 482
10. M.A. Hamidou, D. El Kouri, M. Audrain, and J.Y. Grolleau Systemic antineutrophil cytoplasmic antibody vasculitis associated with lymphoid neoplasia Ann. Rheum. Dis. 60 2001 293 295
11. M.A. Hamidou, S. Derenne, M.A. Audrain, J.M. Berthelot, A. Boumalassa, and J.Y. Grolleau Prevalence of rheumatic manifestations and antineutrophil cytoplasmic antibodies in haematological malignancies. A prospective study Rheumatology (Oxford) 39 2000 417 420
12. V. Auzerie, A. Chiali, A. Bussel, J.C. Brouet, J.P. Fermand, and L. Dubertret Leg ulcers associated with cryoglobulinemia: clinical study of 15 patients and response to treatment Arch. Dermatol. 139 2003 391 393
13. C. Bachmeyer, L. Blum, A.M. Chesneau, J. Richecoeur, F. Testard, and B. Benchaa Raynaud's phenomenon with necrosis of the extremities induced by cold agglutinin disease secondary to a T-cell lymphoma Acta Derm. Venereol. 83 2003 374 375
14. P. Stavem, T. Rorvik, P. Brandtzaeg, F. Brosstad, R. Nordhagen, and P. Grabner Gastric lymphoma causing granulocytopenia and cold intolerance, with recovery after treatment J. Intern. Med. 229 1991 193 196
15. S. Lauchli, L. Widmer, and S. Lautenschlager Cold agglutinin disease - the importance of cutaneous signs Dermatology 202 2001 356 358
16. R. Foti, P. Fazio, G. Lizzio, and R. Leonardi Angioedema: first manifestation of non-Hodgkin's lymphoma Ann. Ital. Med. Int. 17 2002 185 188
17. M.K. Phanish, A. Owen, and D.H. Parry Spontaneous regression of acquired C1 esterase inhibitor deficiency associated with splenic marginal zone lymphoma presenting with recurrent angio-oedema J. Clin. Pathol. 55 2002 789 790
18. S.L. Woodrow, S.E. Munn, T. Basarab, and R. Russel Jones Sweet's syndrome in association with non-Hodgkin's lymphoma Clin. Exp. Dermatol. 21 1996 357 359
19. J.P. Callen Pyoderma gangrenosum Lancet 351 1998 581 585
20. Y. Futei, and I. Konohana A case of erythema elevatum diutinum associated with B-cell lymphoma: a rare distribution involving palms, soles and nails Br. J. Dermatol. 142 2000 116 119
21. A.H. Ropper, and K.C. Gorson Neuropathies associated with paraproteinemia N. Engl. J. Med. 338 1998 1601 1607
22. M. Noguchi, K. Mori, S. Yamazaki, K. Suda, N. Sato, and K. Oshimi Multifocal motor neuropathy caused by a B-cell lymphoma producing a monoclonal IgM autoantibody against peripheral nerve myelin glycolipids GM1 and GD1b Br. J. Haematol. 123 2003 600 605
23. M. Donfrid, S. Apostolski, N. Suvajdzic, G. Jankovic, V. Cemerikic-Martinovic, and H.D. Atkinson Monocytoid B cell lymphoma associated with antibodies to myelin-associated glycoprotein and sulphated glucuronyl paragloboside Acta Haematol. 106 2001 130 132
24. C. Mallecourt, and J.Y. Delattre Neuropathies parańoplasiques Presse Med. 29 2000 447 452
25. C.F. Lucchinetti, D.W. Kimmel, and V.A. Lennon Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies Neurology 50 1998 652 657
26. D. Re, A. Schwenk, P. Hegener, S. Bamborschke, V. Diehl, and H. Tesch Guillain-Barre syndrome in a patient with non-Hodgkin's lymphoma Ann. Oncol. 11 2000 217 220
27. J.M. Vallat, H.A. De Mascarel, D. Bordessoule, M.O. Jauberteau, F. Tabaraud, and A. Gelot Non-Hodgkin malignant lymphomas and peripheral neuropathies - 13 cases Brain 118 Pt 5 1995 1233 1245
28. L. Padua, M.T. Palmisani, G. Di Trapani, A. Evoli, L.M. Larrocca, and P. Tonali Myasthenia gravis and thymic Hodgkin's disease associated in one patient with familial lymphoproliferative disorders Clin. Neuropathol. 13 1994 292 294
29. J.E. Mortimer, and P. Kidd Myasthenia gravis and lymphoblastic lymphoma antiacetylcholine receptor antibody as a tumor marker - a case report Cancer Invest. 7 1989 327 331
30. A.H. Uner, H. Abali, H. Engin, A. Akyol, S. Ruacan, and E. Tan Myasthenia gravis and lymphoblastic lymphoma involving the thymus: a rare association Leuk. Lymphoma 42 2001 527 531
31. K.L. Liu, R. Herbrecht, C. Tranchant, B. Gasser, J.M. Warter, and J.M. Wihlm Malignant thymic lymphoblastic lymphoma and myasthenia gravis: an exceptional association Nouv. Rev. Fr. Hematol. 34 1992 221 223
32. B.A. Hansen, P.S. Sorensen, M.J. Lauritzen, J. Iversen, S. Laulund, and J.E. Petrera A case of malignant lymphoma and myasthenia gravis Scand. J. Haematol. 31 1983 155 160
33. A.P. Batocchi, A. Evoli, S. Servidei, M.T. Palmisani, F. Apollo, and P. Tonali Myasthenia gravis during interferon alfa therapy Neurology 45 1995 382 383
34. P. Sillevis Smitt, A. Kinoshita, B. De Leeuw, W. Moll, M. Coesmans, and D. Jaarsma Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor N. Engl. J. Med. 342 2000 21 27
35. X. Ducrocq, J. Petit, L. Taillandier, V. Dorvaux, R. Anxionnat, and F. Plenat Syndrome opsoclonus-myoclonus parańoplasique ŕv́ lateur d'un lymphome T Presse Med. 28 1999 330 333
36. C.L. Rosen, L. DePalma, and A. Morita Primary angiitis of the central nervous system as a first presentation in Hodgkin's disease: a case report and review of the literature Neurosurgery 46 2000 1504 1508 discussion 08-10
37. I. Genty, M. Michel, O. Hermine, A. Schaeffer, B. Godeau, and H. Rochant Caract́ristiques des ańmies h́molytiques de l'adulte: analyse ŕtrospective de 83 cas Rev. Med. Interne 23 2002 901 909
38. S. Sallah, J.Y. Wan, and L.R. Hanrahan Future development of lymphoproliferative disorders in patients with auto-immune hemolytic anemia Clin. Cancer Res. 7 2001 791 794
39. U. Duhrsen, W. Augener, T. Zwingers, and G. Brittinger Spectrum and frequency of auto-immune derangements in lymphoproliferative disorders: analysis of 637 cases and comparison with myeloproliferative diseases Br. J. Haematol. 67 1987 235 239
40. S. Sallah, G. Sigounas, P. Vos, J.Y. Wan, and N.P. Nguyen Auto-immune hemolytic anemia in patients with non-Hodgkin's lymphoma: characteristics and significance Ann. Oncol. 11 2000 1571 1577
41. D. Crisp, and W. Pruzanski B-cell neoplasms with homogeneous cold-reacting antibodies (cold agglutinins) Am. J. Med. 72 1982 915 922
42. S. Berentsen, K. Bo, F.V. Shammas, A.O. Myking, and E. Ulvestad Chronic cold agglutinin disease of the "idiopathic" type is a premalignant or low-grade malignant lymphoproliferative disease APMIS 105 1997 354 362
43. M. Sivakumaran, P.T. Murphy, D.J. Booker, J.K. Wood, R. Stamps, and R.J. Sokol Paroxysmal cold haemoglobinuria caused by non-Hodgkin's lymphoma Br. J. Haematol. 105 1999 278 279
44. A. Zeidman, Z. Fradin, Y. Barac, D. Bendayan, M. Mittelman, and J. Orlin Splenic lymphoma presenting as warm auto-immune hemolytic anemia associated with pure red cell aplasia Vox Sang. 78 2000 126 129
45. Y. Barrios, A. Plaza, R. Cabrera, and F. Diaz-Espada Autoantibody activity of the immunoglobulin secreted by a follicular B-cell lymphoma APMIS 108 2000 764 770
46. S.E. Jones Auto-immune disorders and malignant lymphoma Cancer 31 1973 1092 1098
47. C. Bachmeyer, J. Audouin, J.L. Bouillot, P. Coutarel, M. Mougeot-Martin, and A. Delmer Immune thrombocytopenic purpura as the presenting feature of gastric MALT lymphoma Am. J. Gastroenterol. 95 2000 1599 1600
48. L. Garderet, M. Aoudjhane, H. Bonte, M. Lagrange, F. Isnard, and L. Fouillard Immune thrombocytopenic purpura: first symptom of gamma/delta T -cell lymphoma Am. J. Med. 111 2001 242 243
49. T. Kubota, K. Tanoue, I. Murohashi, N. Nara, N. Yamamoto, and H. Yamazaki Autoantibody against platelet glycoprotein IIb/IIIa in a patient with non-Hodgkin's lymphoma Thromb. Res. 53 1989 379 386
50. Y. Uesugi, I. Fuse, K. Toba, T. Koike, and A. Shibata Acquired immune thrombocytopenia caused by IgG antiglycoprotein Ib antibody in a patient with Hodgkin's disease Acta. Haematol. 98 1997 217 220
51. A. Nobuoka, S. Sakamaki, K. Kogawa, K. Fujikawa, M. Takahashi, and Y. Hirayama A case of malignant lymphoma producing autoantibody against platelet glycoprotein Ib Int. J. Hematol. 70 1999 200 206
52. U. Malik, J.P. Dutcher, and L. Oleksowicz Acquired Glanzmann's thrombasthenia associated with Hodgkin's lymphoma: a case report and review of the literature Cancer 82 1998 1764 1768
53. T. Lamy Neutroṕnies auto-immunes Rev. Prat. 51 2001 1552 1557
54. M.G. Rose, and N. Berliner T-cell large granular lymphocyte leukemia and related disorders Oncologist 9 2004 247 258
55. V. Gupta, A.J. Eden, and M.J. Mills Helicobacter pylori and auto-immune neutropenia Clin. Lab. Haematol. 24 2002 183 185
56. S. Sallah, and J.Y. Wan Inhibitors against factor VIII in patients with cancer. Analysis of 41 patients Cancer 91 2001 1067 1074
57. S. Sallah, and J.Y. Wan Inhibitors against factor VIII associated with the use of interferon-alpha and fludarabine Thromb. Haemost. 86 2001 1119 1121
58. C.W. Tiplady, P.J. Hamilton, and M.J. Galloway Acquired haemophilia complicating the remission of a patient with high grade non-Hodgkin's lymphoma treated by fludarabine Clin. Lab. Haematol. 22 2000 163 165
59. E.S. Lee, B.K. Hibsman, and H.A. Liebman Acquired bleeding disorder in a patient with malignant lymphoma: antibody-mediated prothrombin deficiency Cancer 91 2001 636 641
60. G.M. Mody, and B. Cassim Rheumatologic manifestations of malignancy Curr. Opin. Rheumatol. 9 1997 75 79
61. P.G. Conaghan, and P.M. Brooks Rheumatic manifestations of malignancy Curr. Opin. Rheumatol. 6 1994 105 110
62. M.R. Cohen, G.E. Carrera, and J. Lundberg Rapidly progressive sacroiliitis in a patient with lymphocytic lymphoma Ann. Rheum. Dis. 52 1993 239 240
63. M. Daneshpouy, D. Bataille, J. Rivet, O. Riviere, P. Morel, and J. Amouroux Peripheral T-cell lymphoma with eosinophilia presenting as monoarthritis: a case study Leuk. Lymphoma 43 2002 1875 1879
64. S. Paira, C. Graf, S. Roverano, and J. Rossini Remitting seronegative symmetrical synovitis with pitting oedema: a study of 12 cases Clin. Rheumatol. 21 2002 146 149
65. A. Olive, J. Del Blanco, M. Pons, M. Vaquero, and X. Tena The clinical spectrum of remitting seronegative symmetrical synovitis with pitting edema. The Catalan Group for the Study of RS3PE J. Rheumatol. 24 1997 333 336
66. F. Trotta, L. Dovigo, G. Scapoli, L. Cavazzini, and G. Castoldi Immunoblastic malignant lymphoma in adult onset Still's disease J. Rheumatol. 20 1993 1788 1792
67. T. Kawasaki, S. Hirohata, T. Hashimoto, H. Miyashita, and F. Tanaka T cell lymphoma masquerading as adult onset Still's disease Clin. Exp. Rheumatol. 13 1995 410 411
68. H. Sono, K. Matsuo, H. Miyazato, M. Sakaguchi, M. Matsuda, and K. Hamada A case of adult-onset Still's disease complicated by non-Hodgkin's lymphoma Lupus 9 2000 468 470
69. J.E. Naschitz, D. Yeshurun, E. Zuckerman, M. Rosenbaum, I. Misselevitch, and I. Shajrawi Cancer-associated fasciitis panniculitis Cancer 73 1994 231 235
70. C.L. Hill, Y. Zhang, B. Sigurgeirsson, E. Pukkala, L. Mellemkjaer, and A. Airio Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study Lancet 357 2001 96 100
71. M. Hasegawa, S. Sato, H. Sakai, T. Ohashi, and K. Takehara Systemic sclerosis revealing T-cell lymphoma Dermatology 198 1999 75 78
72. A. Polliack, and G. Lugassy Auto-immunity and auto-immune syndromes associated with and preceding the development of lymphoproliferative disorders Leukemia 6 Suppl 4 1992 152 154
73. O. Fain, L. Guillevin, G. Kaplan, D. Sicard, V. Lemaire, and P. Godeau Vascularites et cancer. A propos de 14 cas Ann. Med. Interne (Paris) 142 1991 486 504
74. P. Manganelli, G. Ferraccioli, R. Passalacqua, and F. Quaini Polymyalgia rheumatica and malignant neoplasms. A report of 3 cases Recenti Prog. Med. 83 1992 200 202
75. M. Montanaro, and F. Bizzarri Non-Hodgkin's lymphoma and subsequent acute lymphoblastic leukaemia in a patient with polymyalgia rheumatica Br. J. Rheumatol. 31 1992 277 278
76. C. Ferri, L. La Civita, G. Longombardo, A.L. Zignego, and G. Pasero Mixed cryoglobulinaemia: a cross-road between auto-immune and lymphoproliferative disorders Lupus 7 1998 275 279
77. O. Trejo, M. Ramos-Casals, A. Lopez-Guillermo, M. Garcia-Carrasco, J. Yague, and R. Cervera Hematologic malignancies in patients with cryoglobulinemia: association with auto-immune and chronic viral diseases Semin. Arthritis Rheum. 33 2003 19 28
78. V. De Re, S. De Vita, A. Marzotto, M. Rupolo, A. Gloghini, and B. Pivetta Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia Blood 96 2000 3578 3584
79. N. Da'as, A. Polliack, Y. Cohen, G. Amir, D. Darmon, and Y. Kleinman Kidney involvement and renal manifestations in non-Hodgkin's lymphoma and lymphocytic leukemia: a retrospective study in 700 patients Eur. J. Haematol. 67 2001 158 164
80. D.J. Evans, M. Macanovic, M.J. Dunn, and C.D. Pusey Membranous glomerulonephritis associated with follicular B-cell lymphoma and subepithelial deposition of IgG1-kappa paraprotein Nephron Clin Pract 93 2003 c112 c118
81. M.B. Stokes, B. Wood, and E. Alpers Ch Membranoproliferative glomerulonephritis associated with low-grade B cell lymphoma presenting in the kidney Clin. Nephrol. 57 2002 303 309
82. E. Pertuiset, F. Liote, E. Launay-Russ, F. Kemiche, I. Cerf-Payrastre, and A.M. Chesneau Adult Henoch-Schonlein purpura associated with malignancy Semin. Arthritis Rheum. 29 2000 360 367
83. S.R. Peterson, R. Talpur, and M. Duvic Antinuclear antibody seropositivity in patients with cutaneous T-cell lymphoma J. Am. Acad. Dermatol. 39 1998 434 438
84. S. Guyomard, G. Salles, M. Coudurier, H. Rousset, B. Coiffier, and J. Bienvenu Prevalence and pattern of antinuclear autoantibodies in 347 patients with non-Hodgkin's lymphoma Br. J. Haematol. 123 2003 90 99
85. M. Swissa, Y. Cohen, and Y. Shoenfeld Autoantibodies in the sera of patients with lymphoma Leuk. Lymphoma 7 1992 117 122
86. A. Timuragaoglu, A. Duman, G. Ongut, O. Saka, and I. Karadogan The significance of autoantibodies in non-Hodgkin's lymphoma Leuk. Lymphoma 40 2000 119 122
87. I. Genvresse, D. Luftner, E. Spath-Schwalbe, and F. Buttgereit Prevalence and clinical significance of anticardiolipin and anti-beta2-glycoprotein-I antibodies in patients with non-Hodgkin's lymphoma Eur. J. Haematol. 68 2002 84 90
88. A. Sciarra, R. Stasi, E. Stipa, M. Masi, F. Oliva, and M. Olivieri Antiphospholipid antibodies: their prevalence, clinical significance and correlation with cytokine levels in acute myeloid leukemia and non-Hodgkin's lymphoma Recenti Prog. Med. 86 1995 57 62
89. O. Bairey, D. Blickstein, P. Stark, M. Prokocimer, H. Magen Nativ, and I. Kirgner Antiphospholipid Antibodies Are Prevalent at Diagnosis in Non-Hodgkin's Lymphoma Patients and Correlate with Their Survival Blood 102 2003 Abstr. 2328
90. G. Finazzi, V. Brancaccio, M. Moia, N. Ciaverella, M.G. Mazzucconi, and P.C. Schinco Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry Am. J. Med. 100 1996 530 536
91. J.F. Schved, C. Dupuy-Fons, C. Biron, I. Quere, and C. Janbon A prospective epidemiological study on the occurrence of antiphospholipid antibody: the Montpellier Antiphospholipid (MAP) Study Haemostasis 24 1994 175 182
92. M. Sawamura, S. Yamaguchi, H. Murakami, H. Amagai, T. Matsushima, and J. Tamura Multiple autoantibody production in a patient with splenic lymphoma Ann. Hematol. 68 1994 251 254
93. T. Gallart, C. Benito, J.C. Reverter, F. Bosch, M. Blay, and D. Tassies True anti-anionic phospholipid immunoglobulin M antibodies can exert lupus anticoagulant activity Br. J. Haematol. 116 2002 875 886
94. I. Genvresse, F. Buttgereit, E. Spath-Schwalbe, S. Ziemer, J. Eucker, and K. Possinger Arterial thrombosis associated with anticardiolipin and anti-beta2-glycoprotein-I antibodies in patients with non-Hodgkin's lymphoma: a report of two cases Eur. J. Haematol. 65 2000 344 347
95. B.E. Shaw, D. Perry, and A.V. Hoffbrand Progressive arterial thrombosis in a patient with non-Hodgkin's lymphoma, a lupus anticoagulant, factor V Leiden mutation and paraprotein, following chemotherapy Leuk. Lymphoma 42 2001 221 223
96. D. McGuire, A. Zeidman, and M. Mittelman Non-Hodgkin's lymphoma presenting with coagulopathy due to anti-phospholipid antibody syndrome Leuk. Lymphoma 26 1997 193 196
97. V.A. Hill, S.J. Whittaker, B.J. Hunt, K. Liddell, M.F. Spittle, and N.P. Smith Cutaneous necrosis associated with the antiphospholipid syndrome and mycosis fungoides Br. J. Dermatol. 130 1994 92 96
98. S. Andrejevic, B. Bonaci-Nikolic, M. Bukilica, G. Milivojevic, J. Basanovic, and M.M. Nikolic Purpura and leg ulcers in a patient with cryoglobulinaemia, non-Hodgkin's lymphoma, and antiphospholipid syndrome Clin. Exp. Dermatol. 28 2003 151 153
99. A. Carroccio, E. Iannitto, L. Di Prima, S. Cirrincione, R. Troncone, and F. Paparo Screening for celiac disease in non-Hodgkin's lymphoma patients: a serum anti-transglutaminase-based approach Dig. Dis. Sci. 48 2003 1530 1536
100. A. Carroccio, E. Fabiani, E. Iannitto, L. Giannitrapani, F. Gravina, and G. Montalto Tissue transglutaminase autoantibodies in patients with non-Hodgkin's lymphoma. Case reports Digestion 62 2000 271 275
101. A.P. Kourtis, V.A. Boussiotis, P. Lymberi, and G.A. Pangalis Increased natural antibody activity in sera of patients with malignant non-Hodgkin's lymphomas containing paraproteins Am. J. Hematol. 46 1994 283 288
102. C. Thieblemont, A. Mayer, C. Dumontet, Y. Barbier, E. Callet-Bauchu, and P. Felman Primary thyroid lymphoma is a heterogeneous disease J. Clin. Endocrinol. Metab. 87 2002 105 111
103. P.J. Adamson, H. Zola, I.C. Nicholson, G. Pilkington, and A. Hohmann Antibody against CD20 in patients with B cell malignancy Leuk. Res. 25 2001 1047 1050
104. K. Pulford, B. Falini, A.H. Banham, D. Codrington, H. Roberton, and C. Hatton Immune response to the ALK oncogenic tyrosine kinase in patients with anaplastic large-cell lymphoma Blood 96 2000 1605 1607
105. E. Van Den Neste, A. Delannoy, W. Feremans, A. Ferrant, and L. Michaux Second primary tumors and immune phenomena after fludarabine or 2-chloro-2'-deoxyadenosine treatment Leuk. Lymphoma 40 2001 541 550
106. M. Churn, and V. Clough Auto-immune thrombocytopenia associated with the first cycle of fludarabine therapy in the treatment of relapsed non-Hodgkin's lymphoma Clin. Oncol. (R Coll Radiol) 13 2001 273 275
107. J. Braess, K. Reich, S. Willert, F. Strutz, C. Neumann, and W. Hiddemann Mucocutaneous auto-immune syndrome following fludarabine therapy for low-grade non-Hodgkin's lymphoma of B-cell type (B-NHL) Ann. Hematol. 75 1997 227 230
108. K. Tamura, K. Shimaoka, and M. Friedman Thyroid abnormalities associated with treatment of malignant lymphoma Cancer 47 1981 2704 2711
109. F. Ishikawa, H. Shigematsu, H. Gondo, T. Okamura, and Y. Niho Autoreactive antibodies following autologous peripheral blood stem cell transplantation Bone Marrow Transplant. 22 1998 729 731
110. Y.K. Keung, E. Cobos, J. Bolanos-Meade, S. Issarachai, A. Brideau, and D. Morgan Evans syndrome after autologous bone marrow transplant for recurrent Hodgkin's disease Bone Marrow Transplant. 20 1997 1099 1101
111. R. Imamura, H. Inoue, K. Kato, S. Kobayashi, H. Tsukamoto, and K. Nagafuji Development of rheumatoid arthritis following autologous peripheral blood stem cell transplantation Bone Marrow Transplant. 30 2002 527 529
112. O. Hequet, G. Salles, N. Ketterer, D. Espinouse, C. Dumontet, and C. Thieblemont Auto-immune thrombocytopenic purpura after autologous stem cell transplantation Bone Marrow Transplant. 32 2003 89 95
113. A.P. Jillella, A.M. Kallab, and A. Kutlar Auto-immune thrombocytopenia following autologous hematopoietic cell transplantation: review of literature and treatment options Bone Marrow Transplant. 26 2000 925 927
114. M. Sivakumaran, R.M. Hutchinson, H. Pringle, S. Graham, L. Primrose, and J.K. Wood Thrombocytopenia following autologous bone marrow transplantation: evidence for auto-immune aetiology and B cell clonal involvement Bone Marrow Transplant. 15 1995 531 536
115. M. Sanmarco, B. Vialettes, D. Maraninchi, and D. Bernard Autoantibody formation after bone marrow transplantation: a comparison between autologous and allogeneic grafts Auto-immunity 11 1991 7 12
116. E.Y. Chan, J.W. Lawton, A.K. Lie, and C.S. Lau Autoantibody formation after allogeneic bone marrow transplantation: correlation with the reconstitution of CD5+ B cells and occurrence of graft-versus-host disease Pathology 29 1997 184 188
117. K. Chaiwatanatorn, N. Lee, A. Grigg, R. Filshie, and F. Firkin Delayed-onset neutropenia associated with rituximab therapy Br. J. Haematol. 121 2003 913 918
118. E. Voog, F. Morschhauser, and P. Solal-Celigny Neutropenia in patients treated with rituximab N. Engl. J. Med. 348 2003 2691 2694 discussion 91-4
119. E. Jourdan, D. Topart, B. Richard, J. Jourdan, and A. Sotto Severe auto-immune hemolytic anemia following rituximab therapy in a patient with a lymphoproliferative disorder Leuk. Lymphoma 44 2003 889 990
120. T. Papadaki, K. Stamatopoulos, C. Kosmas, G. Paterakis, V. Kapsimali, and G. Kokkini Clonal T-large granular lymphocyte proliferations associated with clonal B cell lymphoproliferative disorders: report of eight cases Leukemia 16 2002 2167 2169
121. L. Varoczy, L. Gergely, M. Zeher, G. Szegedi, and A. Illes Malignant lymphoma-associated auto-immune diseases - a descriptive epidemiological study Rheumatol. Int. 22 2002 233 237
122. V. Jonsson, A. Wiik, K. Hou-Jensen, M. Christiansen, L.P. Ryder, and H.O. Madsen Auto-immunity and extranodal lymphocytic infiltrates in lymphoproliferative disorders J. Intern. Med. 245 1999 277 286
123. G. Dighiero, S. Hart, A. Lim, L. Borche, R. Levy, and R.A. Miller Autoantibody activity of immunoglobulins isolated from B-cell follicular lymphomas Blood 78 1991 581 585
124. C. Thieblemont, P. Felman, F. Berger, C. Dumontet, P. Arnaud, and O. Hequet Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients Clin. Lymphoma 3 2002 41 47
125. H. Murakami, H. Irisawa, T. Saitoh, T. Matsushima, J. Tamura, and M. Sawamura Immunological abnormalities in splenic marginal zone cell lymphoma Am. J. Hematol. 56 1997 173 178
126. C. Thieblemont, P. Felman, E. Callet-Bauchu, A. Traverse-Glehen, G. Salles, and F. Berger Splenic marginal-zone lymphoma: a distinct clinical and pathological entity Lancet Oncol. 4 2003 95 103
127. M. Eck, B. Schmausser, T. Kerkau, A. Greiner, M. Kraus, and W. Fischbach Autoantibodies in gastric MALT-type lymphoma Ann. Oncol. 14 2003 1153 1154
128. Y. Kawahara, K. Yokota, M. Mizuno, N. Yunoki, T. Uesu, and H. Okada Antibodies to human gastric epithelial cells and heat shock protein 60 in Helicobacter pylori positive mucosa associated lymphoid tissue lymphoma Gut 45 1999 20 23
129. M.A. Dimopoulos, P. Panayiotidis, L.A. Moulopoulos, P. Sfikakis, and M. Dalakas Waldenstrom's macroglobulinemia: clinical features, complications, and management J. Clin. Oncol. 18 2000 214 226
130. B. Granel, R. Bouabdallah, J. Serratrice, L. Swiader, V.V. Veit, and N. Horschowski Prelymphomatous presentation of T-cell non-Hodgkin lymphomas. A clinical and histopathological study of 11 cases Eur. J. Intern. Med. 12 2001 57 59
131. W. Siegert, C. Nerl, A. Agthe, M. Engelhard, G. Brittinger, and M. Tiemann Angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma: prognostic impact of clinical observations and laboratory findings at presentation. The Kiel Lymphoma Study Group Ann. Oncol. 6 1995 659 664
132. C.E. Freter, and J. Cossman Angioimmunoblastic lymphadenopathy with dysproteinemia Semin. Oncol. 20 1993 627 635
133. K. Dellagi, J.C. Brouet, and M. Seligmann Antivimentin autoantibodies in angioimmunoblastic lymphadenopathy N. Engl. J. Med. 310 1984 215 218
134. K. Belhadj, F. Reyes, J.P. Farcet, H. Tilly, C. Bastard, and R. Angonin Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients Blood 102 2003 4261 4269
135. G. Motta, F. Vianello, C. Menin, A. De Nicolo, S. Agata, and G. Altavilla Hepatosplenic gammadelta T-cell lymphoma presenting with immune-mediated thrombocytopenia and hemolytic anemia (Evans' syndrome) Am. J. Hematol. 69 2002 272 276
136. H. Tilly, P. Gaulard, E. Lepage, C. Dumontet, J. Diebold, and I. Plantier Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype, and outcome Blood 90 1997 3727 3734
137. J.O. Pers, C. Jamin, F. Predine-Hug, P. Lydyard, and P. Youinou The role of CD5-expressing B cells in health and disease (review) Int. J. Mol. Med. 3 1999 239 245
138. G. Dighiero Auto-immunity and B-cell malignancies Hematol. Cell Ther. 40 1998 1 9
139. N. Yumoto, K. Kurosu, M. Furukawa, and A. Mikata CDR3 sequences of MALT lymphoma show homology with those of autoreactive B-cell lines Jpn. J. Cancer Res. 90 1999 849 857
140. F.K. Stevenson, M.B. Spellerberg, C.J. Chapman, and T.J. Hamblin Differential usage of an autoantibody-associated VH gene, VH4-21, by human B-cell tumors Leuk. Lymphoma 16 1995 379 384
141. F.K. Stevenson, M.B. Spellerberg, J. Treasure, C.J. Chapman, L.E. Silberstein, and T.J. Hamblin Differential usage of an Ig heavy chain variable region gene by human B-cell tumors Blood 82 1993 224 230
142. M.B. Rettig, R.A. Vescio, J. Cao, C.H. Wu, J.C. Lee, and E. Han VH gene usage is multiple myeloma: complete absence of the VH4.21 (VH4-34) gene Blood 87 1996 2846 2852
143. P. Musette, P. Joly, D. Gilbert, E. Marinho, B. Crickx, and F. Tron A paraneoplastic mixed bullous skin disease: breakdown in tolerance to multiple epidermal antigens Br. J. Dermatol. 143 2000 149 153
144. I.R. Mackay, and N.R. Rose Auto-immunity and lymphoma: tribulations of B cells Nat. Immunol. 2 2001 793 795
145. A. Mele, A. Pulsoni, E. Bianco, P. Musto, A. Szklo, and M.G. Sanpaolo Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study Blood 102 2003 996 999
146. C.H. Chan, K.G. Hadlock, S.K. Foung, and S. Levy V(H)1-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen Blood 97 2001 1023 1026
147. E.R. Quinn, C.H. Chan, K.G. Hadlock, S.K. Foung, M. Flint, and S. Levy The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis Blood 98 2001 3745 3749
148. F. Rieux-Laucat, S. Blachere, S. Danielan, J.P. De Villartay, M. Oleastro, and E. Solary Lymphoproliferative syndrome with auto-immunity: A possible genetic basis for dominant expression of the clinical manifestations Blood 94 1999 2575 2582
149. S.E. Straus, E.S. Jaffe, J.M. Puck, J.K. Dale, K.B. Elkon, and A. Rosen-Wolff The development of lymphomas in families with auto-immune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis Blood 98 2001 194 200
150. E. Boulanger, F. Rieux-Laucat, C. Picard, M. Legall, F. Sigaux, and J.P. Clauvel Diffuse large B-cell non-Hodgkin's lymphoma in a patient with auto-immune lymphoproliferative syndrome Br. J. Haematol. 113 2001 432 434
151. S. Poppema, E. Maggio, and A. Van den Berg Development of lymphoma in Auto-immune Lymphoproliferative Syndrome (ALPS) and its relationship to Fas gene mutations Leuk. Lymphoma 45 2004 423 431
152. K. Gronbaek, P.T. Straten, E. Ralfkiaer, V. Ahrenkiel, M.K. Andersen, and N.E. Hansen Somatic Fas mutations in non-Hodgkin's lymphoma: association with extranodal disease and auto-immunity Blood 92 1998 3018 3024
153. J.C. Rathmell, R.L. Elstrom, R.M. Cinalli, and C.B. Thompson Activated Akt promotes increased resting T cell size, CD28-independent T cell growth, and development of auto-immunity and lymphoma Eur. J. Immunol. 33 2003 2223 2232
154. F. Blaes, M. Klotz, H. Huwer, U. Straub, G. Kalweit, and K. Schimrigk Antineural and antinuclear autoantibodies are of prognostic relevance in non-small cell lung cancer Ann. Thorac. Surg. 69 2000 254 258
155. K.N. Syrigos, A. Charalambopoulos, K. Pliarchopoulou, N. Varsamidakis, A. Machairas, and D. Mandrekas The prognostic significance of autoantibodies against dsDNA in patients with colorectal adenocarcinoma Anticancer Res. 20 2000 4351 4353
156. L.Z. Iakoubov, and V.P. Torchilin Nucleosome-releasing treatment makes surviving tumor cells better targets for nucleosome-specific anticancer antibodies Cancer Detect. Prev. 22 1998 470 475
157. L.Z. Iakoubov, and V.P. Torchilin A novel class of antitumor antibodies: nucleosome-restricted antinuclear autoantibodies (ANA) from healthy aged nonauto-immune mice Oncol. Res. 9 1997 439 446
158. V.P. Torchilin, L.Z. Iakoubov, and Z. Estrov Antinuclear autoantibodies as potential antineoplastic agents Trends Immunol. 22 2001 424 427
159. T. Murayama, S. Imoto, T. Takahashi, M. Ito, S. Matozaki, and T. Nakagawa Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia with cyclosporin A Cancer 69 1992 2567 2570
160. S.P. Treon, and K.C. Anderson The use of rituximab in the treatment of malignant and nonmalignant plasma cell disorders Semin. Oncol. 27 2000 79 85
161. R. Stasi, A. Pagano, E. Stipa, and S. Amadori Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura Blood 98 2001 952 957
162. T. Robak Monoclonal antibodies in the treatment of auto-immune cytopenias Eur. J. Haematol. 72 2004 79 88
163. G.J. Silverman, and S. Weisman Rituximab therapy and auto-immune disorders: prospects for anti-B cell therapy Arthritis Rheum. 48 2003 1484 1492
164. F. Zaja, S. De Vita, C. Mazzaro, S. Sacco, D. Damiani, and G. De Marchi Efficacy and safety of rituximab in type II mixed cryoglobulinemia Blood 101 2003 3827 3834
165. N. Layios, E. Van Den Neste, E. Jost, V. Deneys, J.M. Scheiff, and A. Ferrant Remission of severe cold agglutinin disease after Rituximab therapy Leukemia 15 2001 187 188
166. F. Bauduer Rituximab: a very efficient therapy in cold agglutinins and refractory auto-immune haemolytic anaemia associated with CD20-positive, low-grade non-Hodgkin's lymphoma Br. J. Haematol. 112 2001 1085 1086
167. B.G. Somer, D.E. Tsai, L. Downs, B. Weinstein, and S.J. Schuster Improvement in Sjogren's syndrome following therapy with rituximab for marginal zone lymphoma Arthritis Rheum. 49 2003 394 398
168. W. Rosler, B. Manger, R. Repp, J.R. Kalden, and M. Gramatzki Autologous PBPCT in a patient with lymphoma and Sjogren's syndrome: complete remission of lymphoma without control of the auto-immune disease Bone Marrow Transplant. 22 1998 211 213
169. M. Kuwana, S. Nomura, K. Fujimura, T. Nagasawa, Y. Muto, and Y. Kurata Effect of a single injection of humanized anti-CD154 monoclonal antibody on the platelet-specific auto-immune response in patients with immune thrombocytopenic purpura Blood 103 2004 1229 1236